TP53 and breast cancer: Recent studies indicate a strong relationship between p53 and MT, where overexpression of metallothionein is consistently associated with the presence of mutant p53, and in breast cancer, this relationship has been associated with a smaller number of apoptotic cells and a worse prognosis27.